Keywords: nt, amends, terms, memantine, deal, neurobiological, technologies

NT amends terms of memantine deal

Article | 03 March 2008

Neurobiological Technologies has amended a license and cooperation agreement with Germany's Merz Pharmaceuticals GmbH and fellow USA-based Childrens' Medical Center ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Memantine HCL

Namenda

Go to drug listing